Cbdmd Inc. (NASDAQ: YCBD) stock fell by 1.64% at last close whereas the YCBD stock-price gained by 3.67% in the pre-market trading session. CBD tinctures, CBD capsules, CBD gummies, CBD topicals, CBD bath bombs, and CBD pet products are all available from Cbdmd, which is a nationally renowned consumer cannabidiol (CBD) company.
>> 7 Top Picks for the Post-Pandemic Economy <<
Current Update
Cbdmd has set a public price of $7.50 per share for its underwritten public offering of 1,913,100 shares of its 8.0 percent Series A Cumulative Convertible Preferred Stock. The transaction is expected to generate Cbdmd $14,348,250 in gross revenues. The offering is scheduled to close on or around July 1, 2021, pending the fulfillment of normal closing conditions. The shares will be convertible into shares of cbdMD’s common stock at a conversion value of $6.00 per share at the holder’s option, or at a conversion price of $6.00 per share if the selling price of cbdMD’s common stock equals or surpasses $8.25 per share for at least 20 trading days in any 30 trading day period ending five days before the date of notice of conversion. Except in the event of a change of ownership, the shares will not be redeemable until October 16, 2023.
When it comes to discovering hidden gems within the stock market, Stock Wire News has consistently provided invaluable insights. Stock Wire News invites you to explore their upcoming Wealth Building Report. This report will shine a spotlight on little-known companies with the potential for substantial growth in 2024, and it's completely FREE for a limited time.
Claim the free report now by clicking here and start discovering the hidden gems of the market
Sponsored
Read More
The underwriters have been given a 45-day option to acquire up to 286,900 additional shares of 8.0 percent Series A Cumulative Convertible Preferred Stock from cbdMD at the public offering price less the underwriting discount, applicable in whole or in part only to satisfy over-allotments.
Furthermore,
The net proceeds from the transaction will be used by Cbdmd for working capital and other general corporate purposes. The offering’s only book-running manager is ThinkEquity, a part of Fordham Financial Management, Inc.
>> 7 Top Picks for the Post-Pandemic Economy <<
The shares mentioned above are being sold by Cbdmd in accordance with a shelf registration statement on Form S-3 (File No. 333-228773) previously filed with the Securities and Exchange Commission and later declared valid (SEC).